Laddar...
Updated Evaluation of the Safety, Efficacy and Tolerability of Pirfenidone in the Treatment of Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis (IPF) is a chronic fibrotic disease characterized by a progressive decline in lung function with a median survival of 3–5 years after diagnosis. The course of disease is highly variable and unpredictable, often punctuated by episodes of acute respiratory failure, known...
Sparad:
| I publikationen: | Drug Healthc Patient Saf |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7213901/ https://ncbi.nlm.nih.gov/pubmed/32440226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DHPS.S224007 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|